文献速递胸部外周血管PET

对肺栓塞诊断前瞻性研究(PIOPED)闪烁显像数据的临床意义解读

A Clinically Meaningful Interpretation of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) Scintigraphic Data.
PubMed 文献 · Acad Radiol · 2017-03-02

该研究基于PIOPED数据,计算通气/灌注(V/Q)肺闪烁显像及灌注闪烁显像联合胸部X线在改良PIOPED II和PISAPED标准下、各临床预测规则(Wells、Geneva、Miniati、Charlotte)不同概率等级的似然比和验后概率。阳性V/Q和灌注显像的似然比分别为20.6、11和23.7,阴性分别为0.15、0.16和0.2;仅正常结果似然比足够低以排除肺栓塞,阳性结果可确认肺栓塞存在。

要点

  • 阳性V/Q和灌注闪烁显像的似然比分别为20.6、11和23.7,均>10,可确认肺栓塞存在。
  • 阴性V/Q和灌注闪烁显像的似然比分别为0.15、0.16和0.2,仅正常结果似然比足够低以排除肺栓塞。
  • 在三级Wells评分中,初始低临床概率肺栓塞的阳性V/Q显像验后概率为56,初始高临床概率为95。

核心结论

  • 阳性V/Q和灌注闪烁显像结果(似然比>10)可确认肺栓塞存在;仅正常结果似然比足够低以排除肺栓塞。

研究设计与样本

  • 基于PIOPED数据的分析,计算常用临床预测规则(Wells、Geneva、Miniati、Charlotte)在各临床概率等级下,V/Q闪烁显像和灌注闪烁显像联合胸部X线(采用改良PIOPED II和PISAPED标准)的多级似然比和验后概率。

诊断标准与关键数值

  • 阳性V/Q和灌注闪烁显像(改良PIOPED II和PISAPED标准)的似然比分别为20.6、11和23.7。
  • 阴性V/Q和灌注闪烁显像的似然比分别为0.15、0.16和0.2。
  • 三级Wells评分中,初始低临床概率肺栓塞时,V/Q显像阳性、不确定、阴性结果的验后概率分别为56、5和0.9。
  • 三级Wells评分中,初始高临床概率肺栓塞时,V/Q显像阳性、不确定、阴性结果的验后概率分别为95、48和13。

临床应用与阅片要点

  • 可依据似然比将验前概率转换为验后概率,辅助解读V/Q和灌注闪烁显像结果。
  • 阳性V/Q或灌注闪烁显像结果(似然比>10)可确认肺栓塞存在。
  • 仅正常闪烁显像结果似然比足够低,可排除肺栓塞;阴性结果不能排除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Pulmonary embolism (PE) is a common condition associated with significant morbidity and mortality. Diagnostic test characteristics reported in terms of sensitivity and specificity are difficult to translate at the clinical level. More relevant measures are likelihood ratios (LRs), which can convert a pretest into a posttest probability. The aim of our study was to calculate the LRs and posttest probabilities for multiple-level test result for ventilation/perfusion (V/Q) lung scintigraphy and for perfusion scintigraphy combined with chest radiography using modified Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II and the Prospective Investigative Study of Pulmonary Embolism Diagnosis (PISAPED) criteria for each clinical probability level for the most commonly used clinical prediction rules (CPR) using the PIOPED data.

MATERIALS AND METHODS: PE pretest probability was estimated for the most commonly used CPRs (Wells, Geneva, Miniati, and Charlotte) at each clinical probability level (two-, three-, and four-level). Multiple-level LRs (high, indeterminate, low, very low probability, and normal) and the positive, indeterminate, and negative results for V/Q scintigraphy, and the positive, indeterminate, and negative results for perfusion scintigraphy were generated and used to calculate posttest probabilities based on the sensitivity and specificity data from PIOPED for each clinical probability level (low, intermediate, and high) for each CPR. Nomograms were also created.

RESULTS: The LRs for a positive V/Q and perfusion scintigraphy test using modified PIOPED II and PISAPED criteria were 20.6, 11, and 23.7, and for a negative test result were 0.15, 0.16, and 0.2, respectively. In the three-level Wells score, the posttest probability for an initial low clinical probability PE for a positive, indeterminate, and negative test result, respectively, for V/Q scintigraphy is 56, 5, and 0.9; for perfusion scintigraphy with modified PIOPED 40, 7, and 0.9, and with PISAPED 59, not available (N/A), and 1.2; for an initial moderate clinical probability PE for V/Q scintigraphy 86, .22, and 4; for perfusion scintigraphy with modified PIOPED 77, 26, and 5, and with PISAPED 88, N/A, and 6; for an initial high clinical probability of PE for V/Q scintigraphy 95, 48, and 13; and for perfusion scintigraphy with modified PIOPED 92, 53, and 13, and with PISAPED 96, N/A, and 16.

CONCLUSIONS: With LRs >10, a positive test result for V/Q and perfusion scintigraphy can confirm the presence of PE. Only a normal test result has low enough LR to exclude PE.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Cronin P, Dwamena BA. A Clinically Meaningful Interpretation of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) Scintigraphic Data. Acad Radiol. 2017. PMID: 28262522. doi:10.1016/j.acra.2017.01.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。